BR0314629A - Polipeptìdeos de p. ariasi polipeptìdeos de p. perniciosus e métodos e uso - Google Patents
Polipeptìdeos de p. ariasi polipeptìdeos de p. perniciosus e métodos e usoInfo
- Publication number
- BR0314629A BR0314629A BR0314629-4A BR0314629A BR0314629A BR 0314629 A BR0314629 A BR 0314629A BR 0314629 A BR0314629 A BR 0314629A BR 0314629 A BR0314629 A BR 0314629A
- Authority
- BR
- Brazil
- Prior art keywords
- polypeptides
- ariasi
- perniciosus
- methods
- polynucleotides
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/008—Leishmania antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
"POLIPEPTìDEOS DE P. ARIASI, POLIPEPTìDEOS DE P. PERNICIOSUS E MéTODOS DE USO". São descritos polipeptídeos P. ariasi e P. perniciosus salivar substancialmente purificados, e polinucleotídeos codificando estes polipeptídeos. Vetores e células hospedeiras incluindo os polinucleotídeos P. ariasi e P. perniciosus são também descritos. Em uma modalidade, um método é descrito para induzir uma resposta imune à saliva de mosquito-pólvora. Em outras modalidades, são descritos métodos para tratar ou prevenir Leishmaniasis.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41232702P | 2002-09-19 | 2002-09-19 | |
US42585202P | 2002-11-12 | 2002-11-12 | |
PCT/US2003/029833 WO2004027041A2 (en) | 2002-09-19 | 2003-09-18 | P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0314629A true BR0314629A (pt) | 2005-08-02 |
Family
ID=32033599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0314629-4A BR0314629A (pt) | 2002-09-19 | 2003-09-18 | Polipeptìdeos de p. ariasi polipeptìdeos de p. perniciosus e métodos e uso |
Country Status (7)
Country | Link |
---|---|
US (2) | US7741437B2 (pt) |
EP (2) | EP2158917A1 (pt) |
JP (2) | JP2006516883A (pt) |
AU (1) | AU2003275127A1 (pt) |
BR (1) | BR0314629A (pt) |
MX (1) | MXPA05003049A (pt) |
WO (1) | WO2004027041A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7741437B2 (en) | 2002-09-19 | 2010-06-22 | The United States Of America As Represented By The Department Of Health And Human Services | P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
AU2003287267A1 (en) | 2002-10-29 | 2004-05-25 | Centro De Pesquisas Goncalo Moniz | Lutzomyia longipalpis polypeptides and methods of use |
US9101557B2 (en) * | 2011-04-13 | 2015-08-11 | Auburn University | Combination of protein forms for hornfly vaccination |
Family Cites Families (53)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2909462A (en) | 1955-12-08 | 1959-10-20 | Bristol Myers Co | Acrylic acid polymer laxative compositions |
US4036945A (en) | 1976-05-03 | 1977-07-19 | The Massachusetts General Hospital | Composition and method for determining the size and location of myocardial infarcts |
US4444487A (en) | 1979-07-02 | 1984-04-24 | Xerox Corporation | Multiple-flash fuser |
US4331647A (en) | 1980-03-03 | 1982-05-25 | Goldenberg Milton David | Tumor localization and therapy with labeled antibody fragments specific to tumor-associated markers |
US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
US4722848A (en) | 1982-12-08 | 1988-02-02 | Health Research, Incorporated | Method for immunizing animals with synthetically modified vaccinia virus |
GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
US4745051A (en) | 1983-05-27 | 1988-05-17 | The Texas A&M University System | Method for producing a recombinant baculovirus expression vector |
EP0173552B1 (en) | 1984-08-24 | 1991-10-09 | The Upjohn Company | Recombinant dna compounds and the expression of polypeptides such as tpa |
US4745055A (en) | 1985-05-07 | 1988-05-17 | California Biotechnology Inc. | Fused protein for enzyme immunoassay system |
ATE143052T1 (de) | 1986-07-07 | 1996-10-15 | Centocor Inc | Chimärisches murine-mensch-immunoglobulin, spezifisch für tumorassoziertes 17-1a antigen |
US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
IE872455L (en) | 1986-09-12 | 1988-03-12 | Lanstrase Ltd | Improved recombinant expression |
IL84154A0 (en) | 1986-10-16 | 1988-03-31 | Microgenesys Inc | Polypeptides derived from the envelope gene of human immunodeficiency virus in recombinant baculovirus infected insect cells and vaccines against acquired immune deficiency syndrome containing the same |
GB8626412D0 (en) | 1986-11-05 | 1986-12-03 | Clark M R | Antibodies |
GB8717430D0 (en) | 1987-07-23 | 1987-08-26 | Celltech Ltd | Recombinant dna product |
AU622426B2 (en) | 1987-12-11 | 1992-04-09 | Abbott Laboratories | Assay using template-dependent nucleic acid probe reorganization |
DE3743138A1 (de) | 1987-12-18 | 1989-09-14 | Mayr Christian Gmbh & Co Kg | Schleifringlose, elektromagnetische ueberlastkupplung |
EP0425563B1 (en) | 1988-07-20 | 1996-05-15 | David Segev | Process for amplifying and detecting nucleic acid sequences |
CA2003300A1 (en) | 1988-11-21 | 1990-05-21 | Franklin Volvovitz | Skin test and test kit for aids |
US5703055A (en) | 1989-03-21 | 1997-12-30 | Wisconsin Alumni Research Foundation | Generation of antibodies through lipid mediated DNA delivery |
US5397772A (en) * | 1989-06-29 | 1995-03-14 | The President And Fellows Of Harvard College | Vasodilatory peptides from the salivary gland of the sand fly Lutzomyia longipalpis |
US5270202A (en) | 1989-11-03 | 1993-12-14 | Syamal Raychaudhuri | Anti-idiotypic antibodies to human melanoma-associated proteoglycan antigen |
ATE149841T1 (de) | 1990-01-26 | 1997-03-15 | Immunomedics Inc | Impfstoffe gegen krebs und infektionskrankheiten |
US5427930A (en) | 1990-01-26 | 1995-06-27 | Abbott Laboratories | Amplification of target nucleic acids using gap filling ligase chain reaction |
EP0575491B1 (en) | 1991-03-07 | 2003-08-13 | Virogenetics Corporation | Genetically engineered vaccine strain |
US5709860A (en) | 1991-07-25 | 1998-01-20 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
US5585103A (en) | 1991-07-25 | 1996-12-17 | Idec Pharmaceutical Corporation | Induction of cytotoxic T-lymphocyte responses |
US5643578A (en) | 1992-03-23 | 1997-07-01 | University Of Massachusetts Medical Center | Immunization by inoculation of DNA transcription unit |
US5662907A (en) | 1992-08-07 | 1997-09-02 | Cytel Corporation | Induction of anti-tumor cytotoxic T lymphocytes in humans using synthetic peptide epitopes |
EP0671926B1 (en) | 1992-08-11 | 2002-11-13 | President And Fellows Of Harvard College | Immunomodulatory peptides |
US5593972A (en) | 1993-01-26 | 1997-01-14 | The Wistar Institute | Genetic immunization |
PT716697E (pt) | 1993-09-03 | 2003-08-29 | Univ Mcgill | Genes e proteinas de leishmania expressos diferencialmente |
FR2712603B1 (fr) | 1993-11-18 | 1996-02-09 | Centre Nat Rech Scient | Virus recombinants, préparation et utilisation en thérapie génique. |
US5529780A (en) | 1994-03-30 | 1996-06-25 | Virogenetics Corporation | Nucleotide and amino acid sequences of canine herpesvirus gB and gC |
US5648211A (en) | 1994-04-18 | 1997-07-15 | Becton, Dickinson And Company | Strand displacement amplification using thermophilic enzymes |
KR100392551B1 (ko) | 1994-07-15 | 2003-10-30 | 아크조 노벨 엔브이 | 핵산 증폭방법을 개선시키기 위한 rna폴리머라제의 용도 |
EP0826063A1 (en) | 1995-04-25 | 1998-03-04 | Vical Incorporated | Single-vial formulations of dna/lipid complexes |
AT402203B (de) | 1995-06-13 | 1997-03-25 | Himmler Gottfried Dipl Ing Dr | Verfahren zur transkriptionsfreien amplifizierung von nucleinsäuren |
EP0803573A1 (en) | 1996-04-25 | 1997-10-29 | Gesellschaft für Biotechnologische Forschung mbH (GBF) | Polycistronic expression construct with cytokines for multivalent vaccines |
FR2750865B1 (fr) | 1996-06-27 | 1998-12-04 | Rhone Merieux | Vaccin vivant recombinant a base d'herpesvirus canin, notamment contre la maladie de carre, la rage ou le virus parainfluenza de type 2 |
US6090393A (en) | 1996-07-03 | 2000-07-18 | Merial | Recombinant canine adenoviruses, method for making and uses thereof |
US6156567A (en) | 1996-07-03 | 2000-12-05 | Merial | Truncated transcriptionally active cytomegalovirus promoters |
JP2002512501A (ja) | 1996-07-03 | 2002-04-23 | メリアル インコーポレイテッド | 外来性dnaを含む組換えイヌアデノウィルス(cav) |
EP1537877A3 (en) | 1996-10-11 | 2005-08-03 | The Regents Of The University Of California | Immunostimulatory polynucleotide/immunomodulatory molecule conjugates |
CA2306457A1 (en) * | 1997-10-18 | 1999-04-29 | Genetics Institute, Inc. | Secreted proteins and polynucleotides encoding them |
US6248329B1 (en) * | 1998-06-01 | 2001-06-19 | Ramaswamy Chandrashekar | Parasitic helminth cuticlin nucleic acid molecules and uses thereof |
US6017537A (en) | 1998-12-18 | 2000-01-25 | Connaught Laboratories, Inc. | Formyl methionyl peptide vaccine adjuvant |
US6645740B1 (en) | 1999-06-10 | 2003-11-11 | Merial Limited | Nucleic acids encodings equine GM-CSF |
BR0210539A (pt) | 2001-06-19 | 2005-04-26 | Us Gov Health & Human Serv | Processos de seleção e uso de vacinas de vetor antiartrópode |
US7741437B2 (en) | 2002-09-19 | 2010-06-22 | The United States Of America As Represented By The Department Of Health And Human Services | P. ariasi polypeptides, p. perniciosus polypeptides and methods of use |
AU2003287267A1 (en) | 2002-10-29 | 2004-05-25 | Centro De Pesquisas Goncalo Moniz | Lutzomyia longipalpis polypeptides and methods of use |
-
2003
- 2003-09-18 US US10/527,500 patent/US7741437B2/en active Active
- 2003-09-18 JP JP2004538400A patent/JP2006516883A/ja active Pending
- 2003-09-18 AU AU2003275127A patent/AU2003275127A1/en not_active Abandoned
- 2003-09-18 MX MXPA05003049A patent/MXPA05003049A/es active IP Right Grant
- 2003-09-18 EP EP09175598A patent/EP2158917A1/en not_active Ceased
- 2003-09-18 WO PCT/US2003/029833 patent/WO2004027041A2/en active Application Filing
- 2003-09-18 EP EP03759395A patent/EP1545575A4/en not_active Ceased
- 2003-09-18 BR BR0314629-4A patent/BR0314629A/pt not_active Application Discontinuation
-
2008
- 2008-09-30 JP JP2008251982A patent/JP2009060912A/ja active Pending
-
2010
- 2010-04-13 US US12/759,649 patent/US20100196381A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004027041A3 (en) | 2005-02-24 |
JP2009060912A (ja) | 2009-03-26 |
MXPA05003049A (es) | 2005-11-17 |
JP2006516883A (ja) | 2006-07-13 |
EP1545575A4 (en) | 2006-04-05 |
EP2158917A1 (en) | 2010-03-03 |
US7741437B2 (en) | 2010-06-22 |
AU2003275127A1 (en) | 2004-04-08 |
US20100196381A1 (en) | 2010-08-05 |
WO2004027041A2 (en) | 2004-04-01 |
AU2003275127A8 (en) | 2004-04-08 |
US20060004186A1 (en) | 2006-01-05 |
EP1545575A2 (en) | 2005-06-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0200282A (pt) | Sistema e método para determinar exigências especìficas a partir de documentos de exigências gerais | |
ATE440863T1 (de) | Chemokine peptide, varianten, derivate und analoge. ihre verwendung in methode für die hemmung oder erhíhung von einer entzündungsreaktion | |
CY1109439T1 (el) | Αναλογα γλυκοπρωτεϊνικων ορμονων δισουλφιδικης σταυρωτης συνδεσης, η παρασκευη και η χρηση τους | |
BR0316564A (pt) | Forma de dosagem de alérgeno | |
IT1214567B (it) | Struttura di chiodo endomidollare, ed apparecchiatura per il suo inserimento nell'osso. | |
HUP0105337A2 (hu) | Az immunválaszban szerepet játszó új polipeptidek | |
BR9707691A (pt) | Peptídios antipatogênicos e composições que compreendem os mesmos | |
ATE175119T1 (de) | Vakzine gegen immunodefizienz-virus der katze (kiv) | |
DE69515340D1 (de) | Impfstoff gegen mycobakterielle infektionen | |
DK568287A (da) | Relativt lavmolekylaere peptider og deres anvendelse som renininhibitorer | |
ATE355375T1 (de) | Bakterioferritin aus helicobacter pylori | |
BR9710975A (pt) | Genes de proteìna de adesão de superfìcie exposta de 120 kda imunodominante de ehrlichia chaffeensis | |
DE60118359D1 (de) | Humanische pellino-polypeptide | |
BR0314629A (pt) | Polipeptìdeos de p. ariasi polipeptìdeos de p. perniciosus e métodos e uso | |
BR0315872A (pt) | Polipeptìdeos de lutzomyia longipalpis e processos de utilização e método de uso | |
EA200100395A1 (ru) | Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием | |
DE69704807D1 (de) | Tragbarer Tauchcomputer | |
DE59001686D1 (de) | Schutzbrille gegen gase. | |
DK30186A (da) | (1,2,4-oxadiazol-3-yl)-arylmethanoner, fremgangsmaade til fremstilling heraf samt deres anvendelse som medikamenter | |
KR950009817U (ko) | 개인용 컴퓨터의 케이스구조 | |
KR950004499U (ko) | 휴대용 컴퓨터용 외부 케이스 | |
ATE466076T1 (de) | Gewebe transglutaminase | |
ATE144103T1 (de) | Biologischer impfstoff, wirksam gegen aphanomyces | |
KR940023256U (ko) | 개인용 컴퓨터의 전원 확장 장치 | |
BR8604846A (pt) | Teclado ergonomico,reduzido e portatil para microcomputadores e assemelhados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B11E | Dismissal acc. art. 34 of ipl - requirements for examination incomplete | ||
B11T | Dismissal of application maintained [chapter 11.20 patent gazette] |